Cargando…
2770. Intrapulmonary Vaccination with an M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against an RSV Challenge
BACKGROUND: RSV infection is a major cause of lung disease in infants, yet there is no licensed vaccine. We are developing a live RSV vaccine with a deletion of the M protein (“Mnull RSV”). The RSV M protein is responsible for assembling newly synthesized RSV proteins into intact virus. Mnull RSV in...
Autores principales: | Welliver, Robert C, Oomens, Antonius, Preno, Alisha, Papin, James, Ivanov, Vadim, Staats, Rachel, Norris, Abby, Reuter, Nicole, Piedra, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809773/ http://dx.doi.org/10.1093/ofid/ofz360.2447 |
Ejemplares similares
-
M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2017) -
Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017) -
In vitro model for the assessment of human immune responses to subunit RSV vaccines
por: Chirkova, Tatiana, et al.
Publicado: (2020) -
Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017) -
Strategic priorities for respiratory syncytial virus (RSV) vaccine development
por: Anderson, L.J., et al.
Publicado: (2013)